Click here to share with friends and family

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email
Share on reddit
Reddit

“Many researchers are optimistic that antibodies will, relatively quickly, prove their worth as a preventive or remedy that buys the world time until a vaccine arrives—if it does. ‘We’ve got at least 50—and probably more we don’t know about—companies and academic labs that are all racing horses,’ says immunologist Erica Ollmann Saphire of the La Jolla Institute for Immunology, who leads an effort to coordinate and evaluate these candidates. Regeneron Pharmaceuticals, which developed a cocktail of three monoclonal antibodies that worked against the Ebola virus—a notoriously difficult disease to treat—may be out of the gates first with a candidate monoclonal drug entering clinical trials as soon as next month.”

Read more below…

Emma (Ph.D., Founder, PurSolutions)

Emma (Ph.D., Founder, PurSolutions)

Hello world! I'm Emma, a Cell Biologist living in Nashville, TN with experience in biomedical research (Ph.D. from Vanderbilt University), biotech start-ups (co-founder of PurSolutions, LLC), and precision medicine (program specialist at Sarah Cannon, the cancer institute of HCA Healthcare).

Share this resource on:

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email
Share on reddit
Reddit